Strikingly, genes that were down-regulated upon AMPK activation were significantly enriched among genes over-expressed in primary prostate cancer, compared to normal/benign tissue, in both the Grasso and Taylor datasets (NES=−2.00 and NES=−1.61, respectively). This evidence concerns the gene PRKAA2 and prostate carcinoma.